Created using Figma
Created using Figma
M+plus is a supply chain platform with blockchain method in order to distribute pharmaceuticals and functional foods.
Apr 2, 2018
May 17, 2018
100% completed
Raised funds - no Data
Token Details
Accepted Currencies
Company Details
Registered Country
Additional Details


ICO (Initial Coin Offering), is a method for procuring funds by issuing and selling one's own digital tokens. It is not a form of transferring equity like stock procurement, but rather something like crowdfunding, where you simply sell tokens. At the time of this token sale, it is not recognized as "virtual currency". In other words, strictly speaking, ICO is not a "fundraising" method, but rather a "method of selling tokens". On the purchasing side, those giving money to the project would not be "investors," but rather "buyers of tokens". At the present time, m+plus token cannot be used as repayment of consideration for an unspecified person, as there is no exchange market for legal currency, bitcoin, or other existing virtual currency (see article 2, paragraph 5, item 1 of the Settlement of Capital Settlement Act), the above definition also applies to this ICO project.


  • Blockchain- decentralized method used to distribute medical products and health food
  • Halal-certified products 
  • One of our company's products is "Silk Fibroin." Multi-function nano-level silk fibroin fat absorption product. It is officially permitted by the Malaysian government to be imported.

MPLUS (MPL) Roadmap

  • Q1-Q2 2018

  • ICO (Presales) begins;
    Head office facilities transfer to Malaysia;
    Affiliation of major pharmaceutical company in Malaysia;
    Establishment of liaison office in Japan (April 9th).
  • Q3-Q4 2018

  • Block chain distribution platform development begins;
    Halal certified silk fibroin will be determined.
  • Q1-Q2 2019

  • Super placenta medicine approval;
    Block chain platform internal operations commence;
    China, Thailand, Taiwan, South Korea and others join the distribution platform.
  • Q2-Q3 2019

  • Japan affiliates with other major pharmaceutical companies by joining the platform;
    Product manufacturing acceptance of Halal certification to Japanese companies;
    Product distribution to Islamic markets commences.



Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Hirotsugu Tanaka
Akihisa Ishida
Blockchain and Cryptocurrency Developer
Yoshihiro Yamada
Chief Designer
Sayako Kudo
Chief of Customer support team


Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

A.K.Mizanur Rahman
Financial Advisor
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO